AUSTIN, Texas -- Cytoreductive nephrectomy improved overall survival (OS) by more than a year for patients with metastatic renal cell carcinoma (mRCC) with sarcomatoid or rhabdoid (S/R) ...
Established risk factors were confirmed: old age, co-morbidities, significant blood loss and advanced stage of disease. The study also identified modest blood loss (~1L) and conversion from minimally ...
A new study provides insights into the true risks of all types of nephrectomy, or surgical removal of the kidney. By analyzing data on 21,380 nephrectomies performed throughout the United Kingdom, ...
A Canadian study recently assessed 709 patients with intermediate- and high-risk synchronous mRCC with or without sarcomatoid features. Most patients had clear cell histology and were treated with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results